Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK – Get Free Report) announced a dividend on Thursday, May 16th, investing.com reports. Shareholders of record on Tuesday, May 21st will be paid a dividend of 15.10 per share by the biopharmaceutical company on Friday, May 17th. This represents a yield of 99.87%. The ex-dividend date is Monday, May 20th. This […]
Merrimack Pharmaceuticals (NASDAQ:MACK) Share Price Passes Above 200 Day Moving Average of $12 28 kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.
Merrimack Pharmaceuticals, Inc (NASDAQ:MACK) Short Interest Update themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK – Get Free Report) insider Gary L. Crocker purchased 2,000 shares of the business’s stock in a transaction on Thursday, August 10th. The stock was bought at an average cost of $12.52 per share, with a total value of $25,040.00. Following the purchase, the insider now owns 133,105 shares in the […]
StockNews.com downgraded shares of Merrimack Pharmaceuticals (NASDAQ:MACK – Get Rating) from a hold rating to a sell rating in a research report sent to investors on Friday morning. Merrimack Pharmaceuticals Stock Performance Shares of MACK opened at $12.19 on Friday. The business has a 50-day moving average of $12.51 and a 200 day moving average […]